Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank

J Am Heart Assoc. 2018 Feb 10;7(4):e007283. doi: 10.1161/JAHA.117.007283.
No abstract available

Keywords: clinical trial; drug development; outcomes; pediatric cardiology; regulation.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / physiopathology
  • Child
  • Child, Preschool
  • Clinical Trials as Topic / methods*
  • Consensus
  • Drug Development / methods*
  • Endpoint Determination*
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Infant
  • Infant, Newborn
  • Needs Assessment
  • Patient Selection*
  • Stakeholder Participation
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Cardiovascular Agents
  • Hypolipidemic Agents